Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Surface functionalization of liposomes can play a key role in overcoming the current
limitations of nanocarriers to treat solid tumors, ie, biological barriers and physiological …

Affibody molecules are small (6.5-kDa) affinity proteins based on a three-helix bundle
domain framework. Since their introduction 20 years ago as an alternative to antibodies for …

Pharmaceutical nanotechnology introduces novel strategies in designing smart nanoscale
drug delivery systems (NDDSs) capable of responding to specific conditions. These smart …

Research into the application of nanocarriers in the delivery of cancer-fighting drugs has
been a promising research area for decades. On the other hand, their cytotoxic effects on …

This study aims to evaluate the potency of cisplatin (Cispt)-loaded liposome (LCispt) and
PEGylated liposome (PLCispt) as therapeutic nanoformulations in the treatment of bladder …

The use of traditional tools for the targeted delivery of nanostructures, such as antibodies,
transferrin, lectins, or aptamers, often leads to an entire range of undesirable effects. The …

HER2‐positive breast cancer is an aggressive subtype that typically responds poorly to
standard chemotherapy. To design an anticancer drug selective for HER2‐expressing …

Skin is an important organ of the body due to offering an accessible and convenient site for
drug administration. One of the disadvantages of transdermal drug delivery is the low …

The encapsulation of fatty acids in nanocarrier systems is a very effective technique in
improving their biological efficiency and controlled delivery. Nanostructured lipid carrier …